Global Stool Softeners Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Stool Softeners Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
The demand for stool softeners is largely associated with the increasing incidence of constipation. Geriatric patients present a widespread presence of cases of constipation as compared to the younger population. This is due to the lack of physical activity, lack of proper diet, consumption of low-fiber foods, presence of illness and the use of prescribed drugs, which leads to a rise in demand of stool softeners in this population group.
The prevalence rate of constipation is reported to be between 11%-38%, according to the National Institute for Clinical Excellence. Constipation due to pregnancy, and menopausal cases with fluctuations of hormonal levels has also boosted the use of stool softeners globally.
Furthermore, eating disorders sedentary lifestyle, stress, inadequate fluid intake and endocrine or metabolic disorders among many other factors are responsible for the uptake of stool softeners to administer relief over a short-term phase of use.
Stool Softeners report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Stool Softeners market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Stool Softeners industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Stool Softeners key manufacturers include AstraZeneca plc, Teva Pharmaceutical Industries Ltd., Bayer AG, Abbott Laboratories, Aristo Pharmaceuticals Ltd., Mallinckrodt Plc., Unipex, Hunan Warant Chiral Pharmaceutical and Boehringer Ingelheim GmbH, etc. AstraZeneca plc, Teva Pharmaceutical Industries Ltd., Bayer AG are top 3 players and held % sales share in total in 2022.
Stool Softeners can be divided into Liquid, Softgel Capsule and Enema,, etc. Liquid is the mainstream product in the market, accounting for % sales share globally in 2022.
Stool Softeners is widely used in various fields, such as Hospitals, Clinics and Research Institutes,, etc. Hospitals provides greatest supports to the Stool Softeners industry development. In 2022, global % sales of Stool Softeners went into Hospitals filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Stool Softeners market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
AstraZeneca plc
Teva Pharmaceutical Industries Ltd.
Bayer AG
Abbott Laboratories
Aristo Pharmaceuticals Ltd.
Mallinckrodt Plc.
Unipex
Hunan Warant Chiral Pharmaceutical
Boehringer Ingelheim GmbH
Takeda Pharmaceutical Company Ltd
Raptakos Brett & Co. Ltd.
Mylan N.V.
GlaxoSmithKline plc
Stadmed Pvt. Ltd.
Purdue Pharma L.P.
Segment by Type
Liquid
Softgel Capsule
Enema
Hospitals
Clinics
Research Institutes
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Stool Softeners market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Stool Softeners, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Stool Softeners industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Stool Softeners in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Stool Softeners introduction, etc. Stool Softeners Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Stool Softeners market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
The prevalence rate of constipation is reported to be between 11%-38%, according to the National Institute for Clinical Excellence. Constipation due to pregnancy, and menopausal cases with fluctuations of hormonal levels has also boosted the use of stool softeners globally.
Furthermore, eating disorders sedentary lifestyle, stress, inadequate fluid intake and endocrine or metabolic disorders among many other factors are responsible for the uptake of stool softeners to administer relief over a short-term phase of use.
Stool Softeners report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Stool Softeners market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Stool Softeners industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Stool Softeners key manufacturers include AstraZeneca plc, Teva Pharmaceutical Industries Ltd., Bayer AG, Abbott Laboratories, Aristo Pharmaceuticals Ltd., Mallinckrodt Plc., Unipex, Hunan Warant Chiral Pharmaceutical and Boehringer Ingelheim GmbH, etc. AstraZeneca plc, Teva Pharmaceutical Industries Ltd., Bayer AG are top 3 players and held % sales share in total in 2022.
Stool Softeners can be divided into Liquid, Softgel Capsule and Enema,, etc. Liquid is the mainstream product in the market, accounting for % sales share globally in 2022.
Stool Softeners is widely used in various fields, such as Hospitals, Clinics and Research Institutes,, etc. Hospitals provides greatest supports to the Stool Softeners industry development. In 2022, global % sales of Stool Softeners went into Hospitals filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Stool Softeners market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
AstraZeneca plc
Teva Pharmaceutical Industries Ltd.
Bayer AG
Abbott Laboratories
Aristo Pharmaceuticals Ltd.
Mallinckrodt Plc.
Unipex
Hunan Warant Chiral Pharmaceutical
Boehringer Ingelheim GmbH
Takeda Pharmaceutical Company Ltd
Raptakos Brett & Co. Ltd.
Mylan N.V.
GlaxoSmithKline plc
Stadmed Pvt. Ltd.
Purdue Pharma L.P.
Segment by Type
Liquid
Softgel Capsule
Enema
Segment by Application
Hospitals
Clinics
Research Institutes
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Stool Softeners market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Stool Softeners, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Stool Softeners industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Stool Softeners in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Stool Softeners introduction, etc. Stool Softeners Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Stool Softeners market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices